SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-001568
Filing Date
2019-05-15
Accepted
2019-05-15 14:24:12
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cannapharmarx_10q-033119.htm 10-Q 327949
2 COMMERCIAL LEASE AGREEMENT cannapharmarx_10q-ex1003.htm EX-10.3 29746
3 CERTIFICATION cannapharmarx_10q-ex3101.htm EX-31.1 9716
4 CERTIFICATION cannapharmarx_10q-ex3102.htm EX-31.2 9566
5 CERTIFICATION cannapharmarx_10q-ex032.htm EX-32 4262
6 GRAPHIC image_001.jpg GRAPHIC 24248
  Complete submission text file 0001683168-19-001568.txt   2385327

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE cpmd-20190331.xml EX-101.INS 309823
8 XBRL SCHEMA FILE cpmd-20190331.xsd EX-101.SCH 27756
9 XBRL CALCULATION FILE cpmd-20190331_cal.xml EX-101.CAL 51279
10 XBRL DEFINITION FILE cpmd-20190331_def.xml EX-101.DEF 119202
11 XBRL LABEL FILE cpmd-20190331_lab.xml EX-101.LAB 227027
12 XBRL PRESENTATION FILE cpmd-20190331_pre.xml EX-101.PRE 189851
Mailing Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5
Business Address SUITE 3600 888 3RD STREET SW CALGARY A0 T2P 5C5 949-652-6838
CANNAPHARMARX, INC. (Filer) CIK: 0001081938 (see all company filings)

IRS No.: 274635140 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27055 | Film No.: 19827133
SIC: 2834 Pharmaceutical Preparations